Search
Five Questions with Xencor CEO Bassil Dahiyat
- blonca9
- Feb 2, 2024
- 1 min read
Bassil Dahiyat walks us through the latest advances in bi-specific antibody engineering, highlights some key targets of interest, and gives his take on L.A.'s biotech scene.